Abstract
Surgical treatment of head and neck cancer, in certain cases, inflicts large tissue defects. Some of these defects are associated with devastating functional deficits and disfiguring deformities. In addition, radiation therapy, whenever necessary, often leads to wound breakdown, dehiscence and fistula formation, due to healing mechanism impairment. The advent, development, and nowadays routine use of microsurgical techniques has revolutionized the reconstructive approach in this patient population and changed the outcomes dramatically. Free flap use has both ensured the best possible function and aesthetics and become the "gold standard" in complex head and neck reconstruction. Defects of the head and neck can be anatomically grouped into the following categories: a. Skull base, b. Midface, c. Tongue, d. Oral cavity, e. Mandible and f. Hypopharynx, larynx and cervical esophagus. Certain reconstructive goals should be met for each of these categories. Objectives of this article are threefold. First, to report the reconstructive goals in patients with head and neck cancer, second, to outline the indications of free flap use for each category of head and neck defects due to cancer therapy, and third to review in detail the free flap reconstructive options with respect to functional and aesthetic restoration for each kind of defect, according to the recent international literature.
Keywords: Head and neck cancer, tissue defect, microsurgical reconstruction, free flap
Current Cancer Therapy Reviews
Title: Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art
Volume: 2 Issue: 1
Author(s): Efstathios G. Lykoudis, Marios G. Salmas and Dimitrios A. Assimakopoulos
Affiliation:
Keywords: Head and neck cancer, tissue defect, microsurgical reconstruction, free flap
Abstract: Surgical treatment of head and neck cancer, in certain cases, inflicts large tissue defects. Some of these defects are associated with devastating functional deficits and disfiguring deformities. In addition, radiation therapy, whenever necessary, often leads to wound breakdown, dehiscence and fistula formation, due to healing mechanism impairment. The advent, development, and nowadays routine use of microsurgical techniques has revolutionized the reconstructive approach in this patient population and changed the outcomes dramatically. Free flap use has both ensured the best possible function and aesthetics and become the "gold standard" in complex head and neck reconstruction. Defects of the head and neck can be anatomically grouped into the following categories: a. Skull base, b. Midface, c. Tongue, d. Oral cavity, e. Mandible and f. Hypopharynx, larynx and cervical esophagus. Certain reconstructive goals should be met for each of these categories. Objectives of this article are threefold. First, to report the reconstructive goals in patients with head and neck cancer, second, to outline the indications of free flap use for each category of head and neck defects due to cancer therapy, and third to review in detail the free flap reconstructive options with respect to functional and aesthetic restoration for each kind of defect, according to the recent international literature.
Export Options
About this article
Cite this article as:
Lykoudis G. Efstathios, Salmas G. Marios and Assimakopoulos A. Dimitrios, Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art, Current Cancer Therapy Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339406775471768
DOI https://dx.doi.org/10.2174/157339406775471768 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations
Current Drug Targets Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
Current Cancer Drug Targets A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets Effects of Plasma Activated Medium on Head and Neck FaDu Cancerous Cells: Comparison of 3D and 2D Response
Anti-Cancer Agents in Medicinal Chemistry Lactoferrin: A Biologically Active Molecule for Bone Regeneration
Current Medicinal Chemistry Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets Malignant Hypercalcemia
Current Medicinal Chemistry Vitamin D Analogs in Cutaneous Malignancies
Current Pharmaceutical Design Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry Roles of SM22α in Cellular Plasticity and Vascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism
Current Pharmaceutical Design Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Anti-Cancer Agents in Medicinal Chemistry Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Current Medicinal Chemistry Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Positron Emission Tomography in the Diagnosis and Treatment Management of Tuberculosis
Current Pharmaceutical Design Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges
Current Drug Metabolism Current Dendrimer Applications in Cancer Diagnosis and Therapy
Current Topics in Medicinal Chemistry